• News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
|Articles|April 15, 2016

CURE

  • Gastrointestinal Special Issue
  • Volume 1
  • Issue 1

Medical Illustration: Targeting HER2 in Gastric Cancer

Author(s)Erin Moore

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.

ILLUSTRATION BY ERIN MOORE

ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009

*HER2 is also associated with breast cancer.

For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.

Articles in this issue

over 9 years ago

In Gastroesophageal Cancers, Better Prevention and Treatments Needed

over 9 years ago

Cholangiocarcinoma Research is Expanding, But Many Questions Are Still Unanswered

over 9 years ago

The Next Frontier: The Promise of Immunotherapy in Gastrointestinal Cancers

over 9 years ago

Gastrointestinal Stromal Tumors Already Proving to Be Treatable With Targeted Therapies

over 9 years ago

Searching on all Fronts: Changing the Outlook for Those With Pancreatic Cancer

over 9 years ago

Right in the Gut: New Clues About Preventing and Treating Gastric Cancer

over 9 years ago

An Insight Into Gastric Cancers and Life Without a Stomach

almost 10 years ago

Changing Lives With Immunotherapy

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content